Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2).

Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Abstract Text:

R S Sellers,R Zhang,S S Glasson,H D Kim,D Peluso,D A D'Augusta,K Beckwith,E A Morris,

BACKGROUND: Damaged articular cartilage has a limited ability to repair. Operative removal of damaged cartilage and penetration into the subchondral bone to allow population of the defect with progenitor cells can result in filling of the defect with repair tissue. However, this repair tissue often degenerates over time because of its inability to withstand the mechanical forces to which it is subjected. We previously reported that recombinant human bone morphogenetic protein-2 (rhBMP-2) improves the repair of full-thickness defects of cartilage as long as six months postoperatively. We have now extended that study to examine the quality of the repair tissue at one year. METHODS: Full-thickness defects of cartilage were created in the trochlear groove of twenty-five adult New Zealand White rabbits. Eight defects were left empty, eight were filled with a collagen sponge, and nine were filled with a collagen sponge impregnated with five micrograms of rhBMP-2. The animals were killed at fifty-two weeks postoperatively, and the gross appearance of the healed defect was assessed. The repair tissue was examined histologically and was evaluated, according to a grading scale, by four individuals who were blinded with respect to the treatment. The tissue sections were immunostained with antibodies against type-I collagen, type-II collagen, aggrecan, and link protein. The residence time of the rhBMP-2 in the cartilage defect was evaluated in vivo with use of scintigraphic imaging of radiolabeled protein. RESULTS: One year after a single implantation of a collagen sponge containing five micrograms of rhBMP-2, the defects had a significantly better histological appearance than the untreated defects (those left empty or filled with a collagen sponge). The histological features that showed improvement were integration at the margin, cellular morphology, architecture within the defect, and reformation of the tidemark. The total scores were also better for the defects treated with rhBMP-2 than for the untreated defects, but in no instance was the repair tissue identical to normal articular cartilage. The thickness of the cartilage in the defects treated with rhBMP-2 was 70 percent that of the normal cartilage, an observation that was identical to that at twenty-four weeks postoperatively. Immunostaining demonstrated significantly less type-I collagen in the defects treated with rhBMP-2 than in the untreated defects. Immunostaining for other matrix components showed no difference among the treatment groups. The mean residence time of rhBMP-2 in the cartilage defects was eight days with an elimination half-life of 5.6 days. Detectable amounts of rhBMP-2 were present as long as fourteen days after implantation. CONCLUSIONS: The problems associated with operative repair of cartilage include the formation of fibrocartilage rather than normal articular cartilage and the degeneration of that repair tissue over time. Our results demonstrate that the addition of rhBMP-2 to the operative site after creation of a full-thickness defect results in an improvement in the histological appearance and composition of the extracellular matrix at one year postoperatively. If these experimental results translate directly to the clinical situation, it is possible that the addition of rhBMP-2 to existing operative treatments for the repair of cartilage may improve the repair process and may help to maintain the integrity of the repair tissue.

Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Publishing Authors By Initials

RS Sellers,R Zhang,SS Glasson,HD Kim,D Peluso,DA D'Augusta,K Beckwith,EA Morris,

For similar biological phenomena, cell phenomena, and immunity: biological phenomena: regeneration: wound healing research abstracts see: biological phenomena, cell phenomena, and immunity: biological phenomena: regeneration: wound healing research

PUBMED ID PMID:

MEDLINE DATE:

Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: The Journal of bone and joint surgery. American vo

VOLUME: 82

Page Numbers: 151-60

Journal Abbreviation:

ISSN: 0021-9355

DAY: 19

MONTH: Feb

YEAR: 2000

Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 14030

Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Keywords Mesh Terms:

KEYWORDS: Wound Healing

MESH TERMS: physiology

Chemical & Substance for Abstract: Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2). Information

Substance Name: recombinant human bone morphogenetic pro

Registry Number: 0

Grant and Affiliation Information for Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2).

AFFILIATION: Genetics Institute, Incorporated, Cambridge, Massachusetts 02140, USA.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Bone Joint Surg Am

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 rhBMP-2 Related Publications

• BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1.
• Cdc42 and ARP2/3-independent regulation of filopodia by an integral membrane lipid-phosphatase-related protein.
• Cell- and isoform-specific increases in arginase expression in acute silica-induced pulmonary inflammation.
• Characterization of monocarboxylate transport in human kidney HK-2 cells.
• Clinical dementia rating workshop: the Asian experience.
• Deficiency in angiotensin AT1a receptors prevents diabetes-induced hypertension.
• Development of antibodies and chimeric molecules for cancer immunotherapy.
• Driving and dementia in older adults: Implementation and evaluation of a continuing education project.
• Dual Stretch Responses of mHCN2 Pacemaker Channels: Accelerated Activation, Accelerated Deactivation.
• Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis.
• Effect of quercetin on the plasma and intracellular concentrations of saquinavir in healthy adults.
• Flavonoids modulate monocarboxylate transporter-1-mediated transport of gamma-hydroxybutyrate in vitro and in vivo.
• Identifying chemical changes in subchondral bone taken from murine knee joints using Raman spectroscopy.
• Improving standards in orthognathic care: the bigger picture (a national and international perspective).
• Interleukin-1beta signals through a c-Jun N-terminal kinase-dependent inducible nitric oxide synthase and nitric oxide production pathway in Sertoli epithelial cells.
• Nocturnal hypertension in mice consuming a high fructose diet.
• Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.
• Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture.
• Regulation of Product Synthesis in Cell Cultures of Catharanthus roseus. II. Comparison of Production Media1.
• Regulation of Product Synthesis in Cell Cultures of Catharanthus roseus. III. Alkaloid Metabolism in Cultured Leaf Tissue and Primary Callus1.
• Relationship between renal and cardiovascular changes in a murine model of glucose intolerance.
• Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2).
• Retroviral Vectors Encoding a Reverse Transcription-activated Transgene Efficiently Limit Expression of the Gene to Target Cells.
• Role of the transcription activator Ste12p as a repressor of PRY3 expression.
• Rotary spray congealing of a suspension: effect of disk speed and dispersed particle properties.
• Seizures during intracarotid methohexital and amobarbital testing.
• Stress cardiovascular/autonomic interactions in mice.
• The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage.
• The role of infertility nurses in ovulation induction programmes.
• Urinary oxytocin as a non-invasive biomarker for neurohypophyseal hormone secretion.